Variant report
Variant | nsv966088 |
---|---|
Chromosome Location | chr22:23805122-23822357 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:5)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
(count:5 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-IGLL1-2 | chr22:23815565-23815598 | ENSG00000178248 |
2 | lnc-IGLL1-2 | chr22:23816064-23816125 | ENSG00000178248 |
3 | lnc-IGLL1-2 | chr22:23812181-23812224 | ENSG00000178248 |
4 | lnc-IGLL1-2 | chr22:23812995-23813350 | ENSG00000178248 |
5 | lnc-IGLL1-2 | chr22:23812502-23812523 | ENSG00000178248 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs200375680 | chr22:23805123-23805124 | Weak transcription Bivalent Enhancer Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs116787760 | chr22:23805124-23805125 | Weak transcription Bivalent Enhancer Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs553291825 | chr22:23805126-23805127 | Weak transcription Bivalent Enhancer Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs566135745 | chr22:23805127-23805128 | Weak transcription Bivalent Enhancer Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs371368235 | chr22:23805128-23805129 | Weak transcription Bivalent Enhancer Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs17842461 | chr22:23805130-23805131 | Weak transcription Bivalent Enhancer Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs571659537 | chr22:23805137-23805138 | Weak transcription Bivalent Enhancer Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs537489164 | chr22:23805144-23805145 | Weak transcription Bivalent Enhancer Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs201273510 | chr22:23805198-23805199 | Weak transcription Bivalent Enhancer Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs573993882 | chr22:23805234-23805235 | Weak transcription Bivalent Enhancer Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs73389493 | chr22:23805238-23805239 | Weak transcription Bivalent Enhancer Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs528860991 | chr22:23805347-23805348 | Weak transcription Bivalent Enhancer Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs552915092 | chr22:23805376-23805377 | Weak transcription Bivalent Enhancer Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs142012682 | chr22:23805392-23805393 | Weak transcription Bivalent Enhancer Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs150563318 | chr22:23805439-23805440 | Weak transcription Bivalent Enhancer Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs565035908 | chr22:23805474-23805475 | Weak transcription Bivalent Enhancer Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs543904940 | chr22:23805559-23805560 | Weak transcription Bivalent Enhancer Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs139547800 | chr22:23805570-23805571 | Weak transcription Bivalent Enhancer Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs183764145 | chr22:23805616-23805617 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
20 | rs563601516 | chr22:23805633-23805634 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
21 | rs529563023 | chr22:23805657-23805658 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
22 | rs149717526 | chr22:23805668-23805669 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
23 | rs145676445 | chr22:23805683-23805684 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
24 | rs528723753 | chr22:23805684-23805685 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
25 | rs551581407 | chr22:23805708-23805709 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
26 | rs564923460 | chr22:23805713-23805714 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
27 | rs5751674 | chr22:23805714-23805715 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
28 | rs189326375 | chr22:23805777-23805778 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
29 | rs181246466 | chr22:23805798-23805799 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
30 | rs567541348 | chr22:23805800-23805801 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
31 | rs73389494 | chr22:23805806-23805807 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs73389495 | chr22:23805820-23805821 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs5751675 | chr22:23805847-23805848 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs572944517 | chr22:23805943-23805944 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs538876890 | chr22:23805947-23805948 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs139746282 | chr22:23805967-23805968 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs575008731 | chr22:23805985-23805986 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs543775357 | chr22:23805990-23805991 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs560523560 | chr22:23806057-23806058 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs186484802 | chr22:23806127-23806128 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs560392331 | chr22:23806130-23806131 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs113873735 | chr22:23806177-23806178 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs191735920 | chr22:23806227-23806228 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs528630916 | chr22:23806238-23806239 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs376946607 | chr22:23806332-23806333 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs181597741 | chr22:23806412-23806413 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs73389497 | chr22:23806428-23806429 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs531050418 | chr22:23806490-23806491 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs572043048 | chr22:23806507-23806508 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs17615162 | chr22:23806564-23806565 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Velocardiofacial syndrome | 20111667 | CNVD |
Medulloblastoma | 21979893 | CNVD |
sporadic solitary meningiomas | 19589153 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Autism | 22495311 | CNVD |
Emanuel syndrome | 21549014 | CNVD |
Digeorge syndrome | 22283845 | CNVD |
Schizophrenia | 17504246 | CNVD |
Digeorge syndrome | 18033723 | CNVD |
22q11 deletion syndrome | 17034021 | CNVD |
22q11 deletion syndrome | 22511897 | CNVD |
22q11 deletion syndrome | 16829213 | CNVD |
Autism | 22067053 | CNVD |
Autism | 19218893 | CNVD |
Biliary cancer | 22067053 | CNVD |
Congenital heart defect | 21390462 | CNVD |
Digeorge syndrome | 16617304 | CNVD |
Emanuel syndrome | 18184694 | CNVD |
Non-syndromic sensorineural hearing loss | 18184694 | CNVD |
Obsessive-compulsive disorder | 22067053 | CNVD |
Psychosis | 22067053 | CNVD |
Schizophrenia | 19415332 | CNVD |
Schizophrenia | 20587603 | CNVD |
Shprintzen syndrome | 19443537 | CNVD |
absent pulmonary valve syndrome | 16795129 | CNVD |
language delay | 22067053 | CNVD |
periventricular nodular heterotopia | 20648244 | CNVD |
renal disease | 17924346 | CNVD |
Schizophrenia | 20433910 | CNVD |
22q11 deletion syndrome | 17028864 | CNVD |
Schizophrenia | 16969581 | CNVD |
Non-syndromic sensorineural hearing loss | 17135275 | CNVD |
velo-cardio-facial syndrome | 17135275 | CNVD |
Digeorge syndrome | 18787571 | CNVD |
Autism | 18925931 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
22q11.2 microdeletion syndrome | 21547621 | CNVD |
Congenital heart defect | 21308838 | CNVD |
Digeorge syndrome | 16512914 | CNVD |
Digeorge syndrome | 20954168 | CNVD |
Nuchal translucency | 21837766 | CNVD |
Right aortic arch in the fetus | 17066500 | CNVD |
Shprintzen syndrome | 17117043 | CNVD |
Tetralogy of fallot | 17405110 | CNVD |
Velocardiofacial syndrome | 20140301 | CNVD |
Velocardiofacial syndrome | 16512914 | CNVD |
bone mass and metabolism | 20516202 | CNVD |
choanal atresia | 18209138 | CNVD |
extracardiac malformations | 17086578 | CNVD |
fetal heart defects | 21308838 | CNVD |
parathyroid gland dysfunction | 16793949 | CNVD |
prenatal diagnosis | 20453657 | CNVD |
velopharyngeal insufficiency | 19620585 | CNVD |
Prader-willi syndrome | 20942916 | CNVD |
22q11 deletion syndrome | 17653112 | CNVD |
Chronic myelomonocytic leukemia | 16760666 | CNVD |
Non-syndromic sensorineural hearing loss | 16829213 | CNVD |
Non-syndromic sensorineural hearing loss | 16760666 | CNVD |
Chordoma | 21602918 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Congenital heart defect | 22511896 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Seminomas | 18059402 | CNVD |
Cancer | 16751803 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Metachromatic leukodystrophy | 18421352 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Breast cancer | 21858162 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cat eye syndrome | 21549014 | CNVD |
Digeorge syndrome | 21549014 | CNVD |
22q11.2 microdeletion syndrome | 22051516 | CNVD |
22q11.2 microdeletion syndrome | 18483005 | CNVD |
22q11.2 microdeletion syndrome | 19565140 | CNVD |
22q11.2 microdeletion syndrome | 20396437 | CNVD |
22q11.2 microdeletion syndrome | 21390462 | CNVD |
22q11.2 microdeletion syndrome | 21573985 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Autism | 20970697 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Congenital heart defect | 21257016 | CNVD |
Developmental delay | 18414209 | CNVD |
DiGeorge-Velo cardiofacial | 19284877 | CNVD |
Epilepsy | 20970697 | CNVD |
Heart disease | 20551144 | CNVD |
Hughes'' syndrome | 16595601 | CNVD |
Mental retardation | 18414209 | CNVD |
Okamoto syndrome | 19046188 | CNVD |
Primary immunodeficiency | 22566803 | CNVD |
Schizophrenia | 20877625 | CNVD |
Schizophrenia | 20553308 | CNVD |
Schizophrenia | 21956041 | CNVD |
Schizophrenia | 20970697 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Velocardiofacial syndrome | 17556857 | CNVD |
Velocardiofacial syndrome | 20206275 | CNVD |
Velocardiofacial syndrome | 20970697 | CNVD |
delayed speech development | 21274400 | CNVD |
velo-cardio-facial syndrome | 16511839 | CNVD |
velo-cardio-facial syndrome | 21763005 | CNVD |
22q11.2 microdeletion syndrome | 18799940 | CNVD |
Digeorge syndrome | 20877625 | CNVD |
22q11.2 microdeletion syndrome | 18923514 | CNVD |
Congenital heart defect | 22185286 | CNVD |
DiGeorge-Velo cardiofacial | 16773131 | CNVD |
Digeorge syndrome | 20186050 | CNVD |
velo-cardio-facial conotruncal-face syndrome | 20186050 | CNVD |
22q11.2 microdeletion syndrome | 22116936 | CNVD |
Disorders of sex development | 22290220 | CNVD |
22q11.2 duplication syndrome | 18923514 | CNVD |
Autism | 22095694 | CNVD |
Mental retardation | 19951919 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Mental retardation | 16773131 | CNVD |
22q11.2 microdeletion syndrome | 22395003 | CNVD |
22q11.2 microdeletion syndrome | 18691436 | CNVD |
22q11.2 microdeletion syndrome | 18053182 | CNVD |
22q11.2 microdeletion syndrome | 18324686 | CNVD |
22q11.2 microdeletion syndrome | 20074913 | CNVD |
Congenital heart defect | 20802965 | CNVD |
Congenital heart defect | 21134246 | CNVD |
DiGeorge syndrome | 19040613 | CNVD |
DiGeorge-Velo cardiofacial | 18179902 | CNVD |
Digeorge syndrome | 18172682 | CNVD |
Digeorge syndrome | 22470819 | CNVD |
Digeorge syndrome | 21364285 | CNVD |
Neuroendocrine carcinoma | 22470819 | CNVD |
Non-syndromic sensorineural hearing loss | 20069674 | CNVD |
Smith-Magenis syndrome | 18301319 | CNVD |
Tetralogy of fallot | 19144126 | CNVD |
Velo-cardio-facial syndrome | 21364285 | CNVD |
Velocardiofacial syndrome | 18788013 | CNVD |
cardiac malformation | 20573211 | CNVD |
cardiac malformation | 18172682 | CNVD |
velo-cardio-facial syndrome | 18636631 | CNVD |
Schizophrenia | 21822266 | CNVD |
synaptic plasticity | 21368174 | CNVD |
Schizophrenia | 18043741 | CNVD |
sporadic birth defects | 19047251 | CNVD |
Autism | 19046189 | CNVD |
DiGeorge-Velo cardiofacial | 19047251 | CNVD |
Hypernasal speech | 21968682 | CNVD |
Mental retardation | 17339581 | CNVD |
diverse phenotype | 16760730 | CNVD |
Mental retardation | 20152051 | CNVD |
Breast cancer | 16608533 | CNVD |
Melanoma | 18172304 | CNVD |
Ovarian cancer | 22174824 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
DiGeorge-Velo cardiofacial | 17597781 | CNVD |
Digeorge syndrome | 17576883 | CNVD |
Schizophrenia | 18806272 | CNVD |
Schizophrenia | 18990708 | CNVD |
Velocardiofacial syndrome | 17576883 | CNVD |
Schizophrenia | 20075378 | CNVD |
Neurodevelopmental disorder | 17015230 | CNVD |
Neuropsychiatric disorder | 20069037 | CNVD |
Williams-beuren syndrome | 18553513 | CNVD |
Emphysema | 19352772 | CNVD |
Cancer | 17440070 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Asthma | 21956041 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Colorectal cancer | 21128281 | CNVD |
Systemic lupus erythematosus | 21956041 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
22q11.23 microdeletion syndrome | 19193630 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21785460 | CNVD |
Medullary thyroid carcinoma | 18765511 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Schizophrenia | 17989066 | CNVD |
Cancer | 20164919 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Li-fraumeni syndrome | 18685109 | CNVD |
Breast cancer | 20409316 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Cancer | 19424424 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 22522925 | CNVD |
abnormal development | 18461090 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr22:23792800-23812800 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
2 | chr22:23800400-23815200 | Weak transcription | Primary B cells from cord blood | blood |
3 | chr22:23801600-23806800 | Weak transcription | Ovary | ovary |
4 | chr22:23803000-23805600 | Weak transcription | Fetal Intestine Large | intestine |
5 | chr22:23803000-23806000 | Weak transcription | Fetal Intestine Small | intestine |
6 | chr22:23803200-23806800 | Weak transcription | Thymus | Thymus |
7 | chr22:23804800-23806400 | Weak transcription | Fetal Thymus | thymus |
8 | chr22:23805000-23805600 | Strong transcription | Dnd41 | blood |
9 | chr22:23805000-23805800 | Bivalent Enhancer | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
10 | chr22:23805600-23806000 | Weak transcription | Dnd41 | blood |
11 | chr22:23806000-23808600 | Enhancers | Dnd41 | blood |
12 | chr22:23806400-23807200 | Enhancers | Fetal Thymus | thymus |
13 | chr22:23806800-23807000 | Enhancers | Ovary | ovary |
14 | chr22:23806800-23807000 | Enhancers | Thymus | Thymus |
15 | chr22:23807000-23808200 | Weak transcription | Ovary | ovary |
16 | chr22:23807200-23808000 | Weak transcription | Fetal Thymus | thymus |
17 | chr22:23808000-23808800 | Enhancers | Fetal Thymus | thymus |
18 | chr22:23808800-23813000 | Weak transcription | A549 | lung |
19 | chr22:23809400-23810600 | Enhancers | HepG2 | liver |
20 | chr22:23812200-23812400 | Enhancers | HepG2 | liver |
21 | chr22:23812800-23813000 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
22 | chr22:23813000-23814400 | Enhancers | HepG2 | liver |
23 | chr22:23813200-23813400 | Enhancers | A549 | lung |
24 | chr22:23813400-23814000 | Enhancers | Fetal Brain Male | brain |
25 | chr22:23813800-23814200 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
26 | chr22:23814000-23815600 | Enhancers | Primary B cells from peripheral blood | blood |
27 | chr22:23814000-23815600 | Weak transcription | Fetal Brain Male | brain |
28 | chr22:23814200-23815400 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
29 | chr22:23815200-23815400 | Enhancers | Primary B cells from cord blood | blood |
30 | chr22:23815400-23817000 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
31 | chr22:23815600-23816400 | Enhancers | Fetal Brain Male | brain |
32 | chr22:23816000-23816200 | Enhancers | Brain Cingulate Gyrus | brain |
33 | chr22:23816000-23817200 | Enhancers | Brain Germinal Matrix | brain |
34 | chr22:23816200-23817000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
35 | chr22:23816200-23817000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
36 | chr22:23816200-23817000 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
37 | chr22:23816200-23817000 | Enhancers | Brain Inferior Temporal Lobe | brain |
38 | chr22:23819600-23821400 | Enhancers | Dnd41 | blood |
39 | chr22:23820400-23820600 | Enhancers | Small Intestine | intestine |
40 | chr22:23820400-23820800 | Enhancers | Primary T helper memory cells from peripheral blood 1 | blood |
41 | chr22:23820400-23820800 | Enhancers | Primary T helper 17 cells PMA-I stimulated | -- |
42 | chr22:23820600-23821200 | Enhancers | Primary T helper memory cells from peripheral blood 2 | blood |
43 | chr22:23821400-23825200 | Weak transcription | Dnd41 | blood |